SUGAR LAND--October 31, 2014--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--There are more than 1,400 active reported Pharmaceutical-Biotech capital and maintenance (MRO) projects in North America, representing a total investment value (TIV) of nearly $62 billion. According to a recent analysis of Industrial Info's Pharmaceutical-Biotech Industry database, the Mid-Atlantic region is at the top of that investment, accounting for an $8.5 billion portion of that spending divided over 176 projects.

Within this article: Details on the industry's outlook and key projects, including those from major companies such as United Therapeutics Corporation (NASDAQ:UTHR).